What do you do when they grow up? Approaches to seizures in developmentally delayed adults

Epilepsia

Volumn 43, Issue SUPPL. 3, 2002, Pages 71-79

  Devinsky, Orrin ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Behavior; Cerebral palsy; Cognition; Developmental disabilities; Epilepsy; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; LAMOTRIGINE; NEUROLEPTIC AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PSYCHOTROPIC AGENT; VALPROIC ACID;

ADULT; AGGRESSION; ANTICONVULSANT THERAPY; BEHAVIOR DISORDER; CONFERENCE PAPER; DECISION MAKING; DEVELOPMENTAL DISORDER; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; EPILEPSY; HUMAN; INSOMNIA; IRRITABILITY; MENTAL DISEASE; NERVE STIMULATION; PATIENT CARE; PATIENT MONITORING; POPULATION RISK; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; VAGUS NERVE;

ADULT; AGE FACTORS; ANTICONVULSANTS; BRAIN; CHILD; COMORBIDITY; DEATH, SUDDEN; DEVELOPMENTAL DISABILITIES; ELECTRIC STIMULATION THERAPY; EPILEPSY; FEMALE; HUMANS; INCIDENCE; MALE; MENTAL DISORDERS; PSYCHOTROPIC DRUGS; SEIZURES; VAGUS NERVE;

EID: 0036281295     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.43.s.3.2.x     Document Type: Conference Paper

References (77)

1. Outcome of childhood epilepsy: A population-based study with a simple predictive scoring system for those treated with medication
2. Neuropsychiatry of mental retardation and cerebral palsy
3. Epilepsy surgery in children with developmental disabilities
4. Epilepsy among children with mental retardation
5. Active epilepsy in mentally retarded children, I: Prevalence and additional neuroimpairments
6. The risk of seizure recurrence following a first unprovoked seizure: A meta-analysis
7. Relapse following discontinuation of antiepileptic drugs: Meta-analysis
8. Incidence and risk factors in sudden unexpected death in epilepsy: A prospective cohort study
9. Sudden unexplained death in children with epilepsy
10. Community-based antiepileptic treatment in the developmentally disabled
11. Management of adults with cerebral palsy
12. Metabolic and genetic disorders
13. Malformations of cortical development and epilepsy
14. Origins of cerebral palsy
15. Epilepsy in brain-injured children
16. Antecedents of cerebral palsy: Multivariate analysis of risk
17. Antenatal antecedents of moderate and severe cerebral palsy
18. Cerebral palsy in children with epilepsy
19. Mental disorder in adults with mental retardation and epilepsy
20. Epidemiology and prevalence of psychopathology in people with mental retardation
21. Psychotropic drug use in patients with epilepsy and developmental disabilities
22. Psychiatric diagnostic evaluation of mentally retarded individuals
23. Dual diagnosis: Psychiatric disorders in developmental disabilities
24. Symptoms of major depression in mentally retarded adults
25. Psychiatric issues in patients with epilepsy and mental retardation
26. Psychotropic medication use in patients with epilepsy: Effect on seizure frequency
27. Effect of divalproex sodium on aggression and self-injurious behaviour in adults with intellectual disability: A retrospective review
28. Progressive cognitive and behavioral changes in epilepsy
29. Postictal psychosis: A case control series of 20 patients and 150 controls
30. Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability
31. Aggressive behaviour in intellectually challenged patients treated with lamotrigine
32. Gabapentin for behavioral dyscontrol with mental retardation
33. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation
34. Randomized prospective study of early discontinuation of AEDs in children with epilepsy
35. Controlling seizures in children with developmental disabilities: An overview
36. The role of new antiepileptic therapies
37. Phenytoin: Effective but insidious therapy for epilepsy in people with intellectual disability
38. Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability
39. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: A retrospective evaluation
40. Long-term effects of zonisamide in the treatment of epilepsy in children with intellectual disability
41. Treatment of epilepsy in the multiply handicapped
42. Results of barbiturate antiepileptic drug discontinuation on antipsychotic medication dose in individuals with intellectual disability
43. Discontinuation of antiepileptic drug treatment after two seizure-free years in children with cerebral palsy
44. Discontinuance of antiepileptic medications in patients with developmental disability and diagnosis of epilepsy
45. Vagus nerve stimulation for symptomatic generalized epilepsy: A pilot study
46. Adjunctive treatment in Lennox-Gastaut syndrome using vagal nerve stimulation
47. Chronic intermittent stimulation of the left vagal nerve in nine children with Lennox-Gastaut syndrome
48. Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years
49. Vagus nerve stimulation treatment for Lennox-Gastaut syndrome
50. Vagus nerve stimulation for medication-resistant generalized epilepsy
51. Left vagal nerve stimulation in children with refractory epilepsy
52. Vagal nerve stimulation in epileptic encephalopathies
53. Vagus nerve stimulation for the treatment of medically intractable epilepsy
54. Reversibility of temporal-lobe resection of the behavioral abnormalities of temporal-lobe epilepsy
55. Surgical treatment of patients with complex partial seizures
56. Does presurgical IQ predict seizure outcome after temporal lobectomy? Evidence from the Bozeman Epilepsy Consortium
57. Multidisciplinary prediction of seizure freedom from cortical resection surgery
58. Surgical outcome in a group of low-IQ patients with focal epilepsy
59. Developmental disabilities and epilepsy surgery
60. Bilateral resective epilepsy surgery in a child with tuberous sclerosis: Case report
61. Epilepsy surgery in children with tuberous sclerosis complex: Presurgical evaluation and outcome
62. Corpus callosotomy in the developmentally disabled with epilepsy
63. Population-based study of the incidence of sudden unexplained death in epilepsy
64. Risk factors for sudden unexpected death in epilepsy: Case control study
65. Cohort study of incidence of sudden unexplained death in persons with seizure disorder treated with antiepileptic drugs in Saskatchewan, Canada
66. Sudden unexplained death in epilepsy: Observations from a large clinical development program
67. Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden unexpected, unexplained death
68. Seizure control and mortality in epilepsy
69. Sudden unexpected death in epilepsy (SUDEP): An update
70. Sudden unexplained death in epilepsy in adults with mental retardation
71. Lifespan and mortality of epileptic persons with intellectual disability
72. Sudden unexpected death in epilepsy in Victoria
73. Prolonged postictal encephalopathy
74. Circumstances of death in sudden death in epilepsy: Interviews of bereaved relatives
75. Sudden death in epilepsy: A study of incidence in a young cohort with epilepsy and learning difficulty